Role of neuropeptide YY2 receptors in modulation of cardiac parasympathetic neurotransmission

被引:34
作者
Smith-White, MA
Herzog, H
Potter, EK
机构
[1] Prince Wales Hosp, Prince Wales Med Res Inst, Sydney, NSW 2031, Australia
[2] St Vincents Hosp, Garvan Inst Med Res, Sydney, NSW 2010, Australia
基金
英国医学研究理事会;
关键词
neuropeptide YY2 receptor; parasympathetic; Y-2; receptor-knockout; mouse; vagus;
D O I
10.1016/S0167-0115(01)00368-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to clarify the role of the Y-2 receptor in regulation of vagal control of the heart, using Y-2 ((-/-)) receptor-knockout mice. Adult Y-2((+/+).(-/-)) mice (50% C57BL/6-50% 129/SvJ background) were anaesthetised and artificially ventilated. Arterial blood pressure and pulse interval was recorded and both vagus nerves were cut. The cardiac end of the right vagus nerve was stimulated supramaximally every 30 s (7 V, 2-2,5 Hz, 5 s). Neuropeptide Y (NPY) and a Y2 receptor agonist, N-acetyl [Leu(28.31)]NPY 24-36, were injected intravenously in both groups of mice, N-acetyl [Leu(28,31)] NPY 24-36 was also administered to control mice in the presence of a Y-2 receptor antagonist, BIIE0246. Stimulation of the vagus nerve increased pulse interval (PI) by approximately 100 ms. NPY and N-acetyl [Leu(28,31)] NPY 24-36 attenuated the increase in PI evoked by vagal stimulation in control mice only. The attenuation was reduced in the presence of BIIE0246. The results presented here show in Y-2((-/-)) receptor-knockout mice that NPY and N-acetyl [Leu(28,31)] NPY 24-36 have no effect on PI evoked by vagal stimulation. These Findings demonstrate that NPY attenuates parasympathetic activity to the heart via the Y-2 receptor. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 28 条
[1]   BIIE0246:: A selective and high affinity neuropeptide YY2 receptor antagonist [J].
Doods, H ;
Gaida, W ;
Wieland, HA ;
Dollinger, H ;
Schnorrenberg, G ;
Esser, F ;
Engel, W ;
Eberlein, W ;
Rudolf, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 384 (2-3) :R3-R5
[2]   BIIE0246, a potent and highly selective non-peptide neuropeptide YY2 receptor antagonist [J].
Dumont, Y ;
Cadieux, A ;
Doods, H ;
Pheng, LH ;
Abounader, R ;
Hamel, E ;
Jacques, D ;
Regoli, D ;
Quirion, R .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (06) :1075-1088
[3]  
DUMONT Y, 2000, HDB CHEM NEUROANATOM
[4]   SUPPRESSION BY NEUROPEPTIDE-Y OF CAPSAICIN-SENSITIVE SENSORY NERVE-MEDIATED CONTRACTION IN GUINEA-PIG AIRWAYS [J].
GRUNDEMAR, L ;
GRUNDSTROM, N ;
JOHANSSON, IGM ;
ANDERSSON, RGG ;
HAKANSON, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (03) :473-476
[5]   Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices [J].
King, PJ ;
Widdowson, PS ;
Doods, HN ;
Williams, G .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (02) :641-646
[6]   Effect of a selective neuropeptide YY2 receptor antagonist, BIIE0246 on neuropeptide Y release [J].
King, PJ ;
Williams, G ;
Doods, H ;
Widdowson, PS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 396 (01) :R1-R3
[7]   HIGH-LEVELS OF NEUROPEPTIDE-Y IN PERIPHERAL NORADRENERGIC NEURONS IN VARIOUS MAMMALS INCLUDING MAN [J].
LUNDBERG, JM ;
TERENIUS, L ;
HOKFELT, T ;
GOLDSTEIN, M .
NEUROSCIENCE LETTERS, 1983, 42 (02) :167-172
[8]   NEUROPEPTIDE-Y (NPY)-LIKE IMMUNOREACTIVITY IN PERIPHERAL NORADRENERGIC NEURONS AND EFFECTS OF NPY ON SYMPATHETIC FUNCTION [J].
LUNDBERG, JM ;
TERENIUS, L ;
HOKFELT, T ;
MARTLING, CR ;
TATEMOTO, K ;
MUTT, V ;
POLAK, J ;
BLOOM, S ;
GOLDSTEIN, M .
ACTA PHYSIOLOGICA SCANDINAVICA, 1982, 116 (04) :477-480
[9]   CO-RELEASE OF NEUROPEPTIDE-Y AND CATECHOLAMINES DURING PHYSICAL EXERCISE IN MAN [J].
LUNDBERG, JM ;
MARTINSSON, A ;
HEMSEN, A ;
NORHEIM, ET ;
SVEDENHAG, J ;
EKBLOM, B ;
HJEMDAHL, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 133 (01) :30-36
[10]   NEUROPEPTIDE-Y (NPY) DEPRESSES THE SECRETION OF H-3-NORADRENALINE AND THE CONTRACTILE RESPONSE EVOKED BY FIELD STIMULATION, IN RAT VASDEFERENS [J].
LUNDBERG, JM ;
STJARNE, L .
ACTA PHYSIOLOGICA SCANDINAVICA, 1984, 120 (03) :477-479